Lv31
222 积分 2022-11-04 加入
Adherence to endocrine therapy among Chinese patients with breast cancer: current status and recommendations for improvement
1天前
已完结
Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials
1天前
已关闭
Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer
7天前
已完结
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
7天前
已完结
[Bladder cancer incidence, mortality and temporal trends in China]
9天前
已完结
Cancer incidence and mortality in China, 2016
9天前
已完结
Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer
11天前
已完结
P265: Clinicopathologic features, Adjuvant Treatment Patterns and Clinical Outcomes of HR+/HER2- Early Breast Cancer in China
12天前
已完结
Population pharmacokinetic modeling of pyrotinib in patients with HER2-positive advanced or metastatic breast cancer
24天前
已完结
GDC-9545 (Giredestrant): A Potent and Orally Bioavailable Selective Estrogen Receptor Antagonist and Degrader with an Exceptional Preclinical Profile for ER+ Breast Cancer
27天前
已完结
皖公网安备34019202002308
